跳至主要内容
临床试验/PACTR202102893629864
PACTR202102893629864尚未招募未知

Efficacy of dual parenteral artemisinin-based combination therapy for cerebral malaria in a Tripple blind randomized control trial in Nigerian children.

Alao Michael and Co Authors0 个研究点目标入组 359 人开始时间: 2021年2月20日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
359

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 Year(s) 至 5 Year(s)(—)
性别
All

入选标准

  • 1.Children between the ages of 6 months to 17 years as at the last birthday
  • 2.Children with unarousable coma lasting more than 30 minutes in the presence of demonstratable peripheral asexual P. falciparum parasitemia.
  • 3.Children who develop deterioration in their level of consciousness after admission and demonstrate asexual Plasmodium falciparum in the peripheral blood.

排除标准

  • 1.Children with positive biochemical and/or microbiological CSF result consistent with a diagnosis of meningitis
  • 2.Children who have intracranial infections or intracranial space-occupying lesions
  • 3.Children with previous neurological deficit either focal or global

研究者

发起方
Alao Michael and Co Authors

相似试验